its not 100% sure what the influence of this is, but......
the current trial (13 patients) is 6 months from completion (12 month fu on the second group of 5 - 8 patients). The completion of the trial and release of the results will likely have some impact of the company SP and value. However, the publication of the investigation in a peer reviewed scientific journal will also have influence on the acceptance of the product by the medical community. WP reported the investigators want to publish the findings ASAP...but that wont happen until the second half of this year, and the published results could also have an impact on SP.
Lots of factors in the timeline looking forward.
Not advice, Just my 2 c ($20 post consolidation) worth.
AVR Price at posting:
$23.74 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)